Irinotecan Hydrochloride
- Product NDC
- 68001-425
- 11-digit product format
- 680010425
- Labeler code
- 68001
- Product ID
- 68001-425_f1ea10a0-5d80-4b9d-a6cf-1811d058a7f0
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Irinotecan Hydrochloride
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Labeler
- BluePoint Laboratories
- Application
- ANDA208718
- Marketing category
- ANDA
- Marketing start
- 2020-07-07
- Marketing end
- 0000-00-00
- Substance
- IRINOTECAN HYDROCHLORIDE
- Active strength
- 20 mg/mL
- Pharmacologic classes
- Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68001-425-35 | 68001042535 | 1 VIAL in 1 CARTON (68001-425-35) > 2 mL in 1 VIAL | 1 vial | 2020-07-07 | 0000-00-00 | No | No | Current |